MedTrace Logo

Clinical Study on the Immune Response Characteristics of Novel Coronavirus and Influenza Virus Infection

NCT06667063 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2024-10-31

No results posted yet for this study

Summary

This is an open-label, prospective observational study in people 18 years of age and older designed to track changes in the dynamics of the respiratory and peripheral blood immune response in people infected with influenza virus and new coronaviruses, and to resolve the characteristics of the virus-induced natural immune response.

Conditions

Interventions

OTHER

Nasal swab/Nasopharyngeal swab/Blood sample collection

Collect nasal or nasopharyngeal swab samples, 15ml anticoagulant samples and 3ml procoagulant samples, as well as 2ml blood samples for blood routine testing and C-reactive protein testing

OTHER

Nasal swab/Nasopharyngeal swab/Blood draw

Visit 1/2/3：Collect nasal or nasopharyngeal swab samples, 15ml anticoagulant samples and 3ml procoagulant samples, as well as 2ml blood samples for blood routine testing and C-reactive protein testing

OTHER

Nasal swab/Nasopharyngeal swab/Blood draw

Visit 1/2/3：Collect nasal or nasopharyngeal swab samples, 15ml anticoagulant samples and 3ml procoagulant samples, as well as 2ml blood samples for blood routine testing and C-reactive protein testing

Sponsors & Collaborators

  • Institute of Biotechnology, Academy of Military Medical Sciences, PLA of China

    collaborator OTHER

  • Zhongnan Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-09-19
Primary Completion
2024-12-31
Completion
2025-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06667063 on ClinicalTrials.gov